Immunic CEO on strong Q2 progress with vidofludimus calcium trials for MS

By Proactive Investors / August 07, 2025 / www.youtube.com / Article Link

Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt talked with Proactive's Stephen Gunnion about the company's second-quarter ...

Recent News

Market sees gold sector nearing full value overall after target upgrades

August 18, 2025 / www.canadianminingreport.com

Gold stocks gain even as metal pulls back

August 18, 2025 / www.canadianminingreport.com

Gold stocks rocket to new highs, valuations no longer inexpensive

August 11, 2025 / www.canadianminingreport.com

Tariff issue caused by potential definition change of traded gold bars

August 11, 2025 / www.canadianminingreport.com

US BLS head removed after revisions to employment data

August 04, 2025 / www.canadianminingreport.com

See all >